Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Active Shortage

ANANDRON

CHEPLAPHARM ARZNEIMITTEL GMBH

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ANANDRON in Canada?

Yes. ANANDRON 50MG has an active shortage reported to Health Canada (last updated August 8, 2024).

Why is ANANDRON not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will ANANDRON be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusActive Shortage
Same-ingredient products on file3 products
Affected strength50MG
Last updated2024-08-08

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

ANANDRON TAB 50MG

HOECHST ROUSSEL CANADA INC.

50MG · DIN 01989642

Same strengthSame dosage formSame routeNo current shortage

Other Products

ANANDRON TAB 100MG

HOECHST ROUSSEL CANADA INC.

100MG · DIN 01989650

Different strengthSame dosage formSame routeNo current shortage

ANANDRON - TAB 100MG

AVENTIS PHARMA INC

100MG · DIN 02221888

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

DIN

02221861

Strength

50MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

NILUTAMIDE

See all NILUTAMIDE products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History